DXN is trading at A$0.45 (+7.14%) after investors reassessed FY26 results and the company’s record forward backlog of approximately A$40 million.

  • FY26 revenue declined 33% to A$10.1 million amid project deferrals.
  • Approximately 45% of the backlog is expected as first-half FY27 revenue.
  • The move extends recent gains from A$0.42 on September 4.